1-Triazene,3,3-dimethyl-1-(3-methylphenyl)-

Suppliers

Names

[ CAS No. ]:
20241-03-6

[ Name ]:
1-Triazene,3,3-dimethyl-1-(3-methylphenyl)-

Chemical & Physical Properties

[ Density]:
0.98g/cm3

[ Boiling Point ]:
237.1ºC at 760mmHg

[ Molecular Formula ]:
C9H13N3

[ Molecular Weight ]:
163.22000

[ Flash Point ]:
97.2ºC

[ Exact Mass ]:
163.11100

[ PSA ]:
27.96000

[ LogP ]:
2.55530

[ Vapour Pressure ]:
0.0457mmHg at 25°C

[ Index of Refraction ]:
1.524

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XY1300000
CHEMICAL NAME :
Triazene, 3,3-dimethyl-1-(m-methylphenyl)-
CAS REGISTRY NUMBER :
20241-03-6
LAST UPDATED :
199612
DATA ITEMS CITED :
7
MOLECULAR FORMULA :
C9-H13-N3
MOLECULAR WEIGHT :
163.25
WISWESSER LINE NOTATION :
1N1&NUNR C1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
201 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
250 mg/kg
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - colon tumors Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2700 mg/kg/56W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors Skin and Appendages - tumors

MUTATION DATA

TYPE OF TEST :
Mutation in microorganisms
TEST SYSTEM :
Bacteria - Salmonella typhimurium
DOSE/DURATION :
400 nmol/L
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 22,473,1979

Safety Information

[ HS Code ]:
2928000090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Dimethylamine
  • 3-Toluidine

DownStream

  • 2-(M-TOLYL)ISONICOTINIC ACID
  • 3-(M-Tolyl)isonicotinic acid
  • 3-methylbenzenediazonium
  • Dimethylamine
  • 4-METHYL-2-M-TOLYL-PYRIDINE
  • 4-methyl-3-(m-tolyl)pyridine
  • 3-(3-Methylphenyl)pyridine

Customs

[ HS Code ]: 2928000090

[ Summary ]:
2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

Related Compounds

  • 1-Triazene,3,3-dimethyl-1-(2-methylphenyl)-
  • 1-Triazene,3,3-dimethyl-1-(4-methylphenyl)-
  • 1-Triazene,3,3-dimethyl-1-[4-nitro-3-(trifluoromethyl)phenyl]-
  • 1-Triazene,3,3-dimethyl-1-phenyl-
  • 1-Triazene,3,3-dimethyl-1-phenyl-, 1-oxide
  • 1-Triazene,3,3-dimethyl-1-(4-nitrophenyl)-
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 2-(1-Methyl-1H-pyrazol-4-yl)quinolin-4-amine
  • N-Ethyl-N-[1-(2,2,2-trifluoroethyl)pyrrolidin-3-yl]but-2-ynamide
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-[2-(4-Tert-butyl-3,6-dihydro-2H-pyridin-1-yl)ethyl]prop-2-enamide
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde